News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson (JNJ)     9/21/2017
Amgen (AMGN), Allergan (AGN) Make History With First Cancer Biosimilar OK—Will Take on Genentech (RHHBY)'s $6 Billion Best-Seller     9/18/2017
Show Me The Money: Bay Area’s Top 5 Venture Capital-Backed Biotechs     9/18/2017
FDA Calls Regeneron (REGN), Sanofi (SNY) Carcinoma Drug a Breakthrough     9/15/2017
Gathering the Ingredients for Precision Medicine     9/12/2017
7 PDUFA Dates to Mark on Your Calendars for September     9/7/2017
Investors Wait with Bated Breath for AstraZeneca PLC (AZN)'s Cancer Trial Data Next Week     9/1/2017
This Drug Could be the Most Crucial in Regeneron (REGN)'s Massive Pipeline     8/24/2017
How Roche (RHHBY) Fine-Tuned an Old Drug Under a New Name to Keep Making Profits     8/24/2017
These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates     8/22/2017
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+     8/17/2017
This is What Happens When the FDA Approves Cancer Drugs Too Quickly     8/17/2017
Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma     8/15/2017
AstraZeneca PLC (AZN) Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. (MRK)     7/28/2017
Google (GOOG) Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily (GOOGL) Campus to Sweeten Deal     7/27/2017

News from Around the Web
Down But Not Out: Juno (JUNO) Preps For Second Round Of CAR-T Cancer War     9/18/2017
IBM (IBM) Pitched Its Watson Supercomputer As A Revolution In Cancer Care. It’s Nowhere Close     9/18/2017
Revolutionary Pen Could Detect Cancer In 10 Seconds, University of Texas Study     9/11/2017
Cancer Breakthroughs Can Quickly Become Tomorrow's Also-Ran     9/6/2017
Novartis AG (NVS) CEO: Here's How We Handled A Milestone In Pediatric Cancer     9/5/2017
A New Heart Disease Test Flings Color Genomics Into A Battle About Genetics In Medicine     8/11/2017
Glowing Tumor Technology Helps Surgeons Remove Hidden Cancer Cells, University of Pennsylvania School of Medicine Reveals     7/28/2017
The Startling History Behind Merck & Co. (MRK)'s New Cancer Blockbuster     7/26/2017
Nanoparticles Loaded With Component Of Common Spice Kill Cancer Cells, Nanoscale Reveals     7/26/2017
The Problem With Saying John McCain Can 'Fight' His Cancer     7/25/2017
University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors     7/20/2017
Top 10 Therapeutic Areas In Biopharma R&D     7/18/2017
Google (GOOG) Search Data Can Predict Cancer Incidence And Mortality     6/30/2017
Vaccine To Slow Cancer Growth Closer To Human Trials, University of Sydney Reveals     6/28/2017
Thwarting Metastasis By Breaking Cancer's Legs With Gold Rods, Georgia Institute of Technology Study     6/28/2017

Press Releases
NUST MISIS Scientists Develop Gold Nanoparticles For Cancer Treatment     9/22/2017
FLX Bio Selects Immuno-Oncology Clinical Candidate     9/21/2017
ProBion Innovation Sweden Announces Colon Cancer Breakthrough: New Probiotic Treatment Markedly Reduces Cancer-Related Microbes     9/21/2017
OncoQR ML's Vaccine Platform Closes The Final Gap In The Immunological Attack Against Cancer     9/21/2017
Cancer Genetics (CGIX) Announces 25th Contract Win To Provide Testing & Diagnostic Services For Combination Immuno-Oncology Clinical Trial     9/20/2017
Salk Institute for Biological Studies Release: MicroRNA Helps Cancer Evade Immune System     9/19/2017
U.S. Medical Innovations, LLC And The George Washington University Sign A $5.3 Million Agreement To Launch A New Plasma-Based Cancer Therapy Program     9/19/2017
Agilent (A) Announces Expanded Use Of Cancer Diagnostic In The United States     9/19/2017
Formula Pharmaceuticals, Inc. Announces Initiation Of The First Clinical Trial For Allogeneic CIK-CAR Cancer Immunotherapy     9/18/2017
Karus Therapeutics Announces First Cancer Patients Dosed With KA2507, A Small Molecule HDAC6-Selective Inhibitor, In A Phase I Clinical Trial     9/18/2017
Champions Oncology (CSBR) Announces Publication Highlighting Clinical Correlation Between Patient-Derived Xenograft (PDX) Model Responses And Patient Responses To Oncology Therapies     9/18/2017
RedHill Biopharma (RDHL) Receives Notice Of Allowance For A New U.S. Patent Covering Its Combination Therapy For Hard-To-Treat Cancers     9/18/2017
Tesaro (TSRO) Receives Positive CHMP Opinion For ZEJULA     9/15/2017
Fennec Pharma Announces Preliminary Results Of SIOPEL 6 Study On PEDMARK (Sodium Thiosulfate) To Be Presented At The 49TH Congress Of The International Society Of Pediatric Oncology (SIOP) 2017 Meeting     9/14/2017
Mustang Bio Announces Expansion Of CAR T Pipeline Into CD20-Directed Immunotherapies     9/14/2017